Texas court ruling on abortion pill opens FDA and its approval decisions to wider political attacks
Should partisan judges be allowed to make or overturn drug approval decisions, or should the nonpartisan FDA scientists and doctors continue to make these decisions for a living? That’s the crux of the question facing the US, as a Texas judge late Friday sought to halt the approval of a pill to end early pregnancies that’s been marketed safely for more than two decades.
The Texas court ruling sets up a major political and legal battle, representing the latest push to further restrict abortion access in a post-Roe world as currently more than half of all pregnancies up to 10 weeks’ gestation are performed with the drug in question, mifepristone, in combo with misoprostol.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.